| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20035595 | HPV | ENSG00000114200.10 | protein_coding | BCHE | No | No | 590 | P06276 |
| TVIS20036389 | HPV | ENSG00000114200.10 | protein_coding | BCHE | No | No | 590 | P06276 |
| TVIS44015269 | HTLV-1 | ENSG00000114200.10 | protein_coding | BCHE | No | No | 590 | P06276 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | BCHE |
|---|---|
| DrugBank ID | DB01226 |
| Drug Name | Mivacurium |
| Target ID | BE0002180 |
| UniProt ID | P06276 |
| Regulation Type | |
| PubMed IDs | 8922768 |
| Citations | Kao YJ, Le ND: The reversal of profound mivacurium-induced neuromuscular blockade. Can J Anaesth. 1996 Nov;43(11):1128-33. |
| Groups | Approved |
| Direct Classification | Benzylisoquinolines |
| SMILES | COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC |
| Pathways | |
| PharmGKB | PA450528 |
| ChEMBL | CHEMBL1182833 |
